Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Protegrin structure and activity against Neisseria gonorrhoeae.

Qu XD, Harwig SS, Shafer WM, Lehrer RI.

Infect Immun. 1997 Feb;65(2):636-9.

2.

Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.

Lee IH, Zhao C, Cho Y, Harwig SS, Cooper EL, Lehrer RI.

FEBS Lett. 1997 Jan 3;400(2):158-62.

3.

[Defensins and antibiotic peptides related to them in the evolution of animal protective systems].

Kokriakov VN, Stefanov VE, Aleshina GM, Shamova OV, Korneva EA, Harwig SS, Lehrer RI.

Zh Evol Biokhim Fiziol. 1997 Jan-Feb;33(1):109-23. Review. Russian. No abstract available.

PMID:
9412106
4.

Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis.

Yasin B, Lehrer RI, Harwig SS, Wagar EA.

Infect Immun. 1996 Nov;64(11):4863-6.

5.
6.

Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes.

Fahrner RL, Dieckmann T, Harwig SS, Lehrer RI, Eisenberg D, Feigon J.

Chem Biol. 1996 Jul;3(7):543-50.

7.

Susceptibility of Neisseria gonorrhoeae to protegrins.

Qu XD, Harwig SS, Oren AM, Shafer WM, Lehrer RI.

Infect Immun. 1996 Apr;64(4):1240-5.

8.

Intramolecular inhibition of human defensin HNP-1 by its propiece.

Valore EV, Martin E, Harwig SS, Ganz T.

J Clin Invest. 1996 Apr 1;97(7):1624-9.

9.

Susceptibility of Chlamydia trachomatis to protegrins and defensins.

Yasin B, Harwig SS, Lehrer RI, Wagar EA.

Infect Immun. 1996 Mar;64(3):709-13.

10.

Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes.

Harwig SS, Swiderek KM, Lee TD, Lehrer RI.

J Pept Sci. 1995 May-Jun;1(3):207-15.

PMID:
9222998
11.

Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.

Harwig SS, Kokryakov VN, Swiderek KM, Aleshina GM, Zhao C, Lehrer RI.

FEBS Lett. 1995 Mar 27;362(1):65-9.

12.

Bactericidal properties of murine intestinal phospholipase A2.

Harwig SS, Tan L, Qu XD, Cho Y, Eisenhauer PB, Lehrer RI.

J Clin Invest. 1995 Feb;95(2):603-10.

13.

Identification of CG-1, a natural peptide antibiotic derived from human neutrophil cathepsin G.

Miyasaki KT, Qu XD, Harwig SS, Cho Y, Lehrer RI.

Adv Dent Res. 1995 Feb;9(1):63-6.

PMID:
7669217
14.

Cryptdins: endogenous antibiotic peptides of small intestinal Paneth cells.

Harwig SS, Eisenhauer PB, Chen NP, Lehrer RI.

Adv Exp Med Biol. 1995;371A:251-5.

PMID:
8525919
15.

Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.

Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.

FEBS Lett. 1994 Apr 11;342(3):281-5.

16.

Neutrophil defensins: purification, characterization, and antimicrobial testing.

Harwig SS, Ganz T, Lehrer RI.

Methods Enzymol. 1994;236:160-72. No abstract available.

PMID:
7968608
17.

In vitro candidastatic properties of the human neutrophil calprotectin complex.

Murthy AR, Lehrer RI, Harwig SS, Miyasaki KT.

J Immunol. 1993 Dec 1;151(11):6291-301.

PMID:
8245468
18.

Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.

Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.

FEBS Lett. 1993 Jul 26;327(2):231-6.

19.

Antimicrobial proteins of murine macrophages.

Hiemstra PS, Eisenhauer PB, Harwig SS, van den Barselaar MT, van Furth R, Lehrer RI.

Infect Immun. 1993 Jul;61(7):3038-46.

20.
21.

[Rat bladder ubiquitin-like molecule: isolation, purification and N-terminal sequencing].

Wang B, Harwig SS, Lehrer RI.

Hua Xi Yi Ke Da Xue Xue Bao. 1993 Jun;24(2):127-30. Chinese.

PMID:
8244287
22.
23.

eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.

Couto MA, Harwig SS, Cullor JS, Hughes JP, Lehrer RI.

Infect Immun. 1992 Dec;60(12):5042-7.

24.

Cryptdins: antimicrobial defensins of the murine small intestine.

Eisenhauer PB, Harwig SS, Lehrer RI.

Infect Immun. 1992 Sep;60(9):3556-65.

25.

Identification of eNAP-1, an antimicrobial peptide from equine neutrophils.

Couto MA, Harwig SS, Cullor JS, Hughes JP, Lehrer RI.

Infect Immun. 1992 Aug;60(8):3065-71.

26.

Characterization of defensin precursors in mature human neutrophils.

Harwig SS, Park AS, Lehrer RI.

Blood. 1992 Mar 15;79(6):1532-7.

PMID:
1547345
27.

Ultrasensitive assays for endogenous antimicrobial polypeptides.

Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P.

J Immunol Methods. 1991 Mar 21;137(2):167-73.

PMID:
1901580
28.

Polymorphic expression of defensins in neutrophils from outbred rats.

Eisenhauer P, Harwig SS, Szklarek D, Ganz T, Lehrer RI.

Infect Immun. 1990 Dec;58(12):3899-902.

29.

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME.

J Clin Invest. 1989 Aug;84(2):553-61.

30.

Purification and antimicrobial properties of three defensins from rat neutrophils.

Eisenhauer PB, Harwig SS, Szklarek D, Ganz T, Selsted ME, Lehrer RI.

Infect Immun. 1989 Jul;57(7):2021-7.

31.
32.
33.

Effects of phorbol diesters and teleocidin on normal human platelets.

Cech P, Rosove MH, Harwig SS, Lehrer RI.

Thromb Res. 1986 May 1;42(3):383-96.

PMID:
2940726
34.

Primary structures of three human neutrophil defensins.

Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI.

J Clin Invest. 1985 Oct;76(4):1436-9.

35.

Defensins. Natural peptide antibiotics of human neutrophils.

Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI.

J Clin Invest. 1985 Oct;76(4):1427-35.

36.

Dissociation of thrombin generation and platelet secretion in diabetes mellitus.

Rosove MH, Berliner JA, Harwig SS, Frank HJ.

Diabetes Res. 1985 Jul;2(4):171-3.

PMID:
2935351
37.

Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils.

Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI.

J Biol Chem. 1985 Apr 25;260(8):4579-84.

38.
39.

Dapsone and Heinz bodies.

Rosove MH, Harwig SS, Ahmed RA.

Arch Dermatol. 1985 Jan;121(1):25. No abstract available.

PMID:
3966817
41.

Confirmation that ethanol potentiates aspirin-induced prolongation of the bleeding time.

Rosove MH, Harwig SS.

Thromb Res. 1983 Aug 1;31(3):525-7. No abstract available.

PMID:
20218009
42.
43.

123I-labeled soluble fibrin: preparation and comparison with other thrombus imaging agents.

Harwig JF, Harwig SS, Eichling JO, Coleman RE, Welch MJ.

Int J Appl Radiat Isot. 1977 Jan-Feb;28(1-2):157-62. No abstract available.

PMID:
852909
44.

Solid phase bovine thrombin. Preparation and properties.

Harwig SS, Lee JL, Sherman LA, Harwig JF, Welch MJ.

Biochim Biophys Acta. 1976 Jun 7;438(1):231-8.

PMID:
945753
45.

Letter: Preparation of 99mTc-fibrinogen.

Harwig SS, Harwig JF, Welch MJ.

J Nucl Med. 1976 Feb;17(02):151-3. No abstract available.

46.

Preparation and in vitro properties of 99mTc-fibrinogen.

Harwig JF, Harwig SS, Wells LD, Welch MJ.

Int J Appl Radiat Isot. 1976 Jan;27(1):5-13. No abstract available.

PMID:
1245359
47.

In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent.

Harwig SS, Harwig JF, Coleman RE, Welch MJ.

J Nucl Med. 1976 Jan;17(1):40-6.

48.

Highly iodinated fibrinogen: a new thrombus-localizing agent.

Harwig JF, Coleman RE, Harwig SS, Sherman LA, Siegel BA, Welch MJ.

J Nucl Med. 1975 Aug;16(8):756-63.

49.

Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog.

Coleman RE, Harwig SS, Harwig JF, Sherman LA, Welch MJ.

Circ Res. 1975 Jul;37(1):35-40.

PMID:
1149186
50.

Fibrinogen uptake by thrombi: effect of thrombus age.

Coleman RE, Harwig SS, Harwig JF, Siegel BA, Welch MJ.

J Nucl Med. 1975 May;16(5):370-3.

Supplemental Content

Loading ...
Support Center